日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of antibody-drug conjugates targeting L1CAM to treat metastatic cancer

开发靶向L1CAM的抗体药物偶联物以治疗转移性癌症

Park, Jin Suk; Kenum, Carson; He, Lan; Khan, Abdul G; Pohl, Mary Ann; White, Thomas E; Kodangattil, Sreekumar R; Rudin, Charles M; Balderes, Paul J; Lorenz, Ivo C; Massagué, Joan; Ganesh, Karuna

Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma.

双重 ALK/FAK 抑制剂 ESK440 在 ALK 驱动的神经母细胞瘤中的治疗益处

Chugh Seema, Tien Jean C, Hon Jennifer, Kenum Carson, Mannan Rahul, Cheng Yunhui, Li Chi Chiang, Taher Zainab I, Delekta Andrew D, Bawa Pushpinder Singh, Apel Ingrid J, Miner Stephanie J, Cao Xuhong, Mehra Rohit, Dhanasekaran Saravana M, Qiao Yuanyuan, Mody Rajen, Chinnaiyan Arul M

Development of antibody-drug conjugates targeting L1CAM to treat metastatic cancer

开发靶向L1CAM的抗体药物偶联物以治疗转移性癌症

Park, Jin Suk; Kenum, Carson; He, Lan; Khan, Abdul G; Pohl, Mary Ann; White, Thomas E; Kodangattil, Sreekumar R; Rudin, Charles M; Balderes, Paul J; Lorenz, Ivo C; Massagué, Joan; Ganesh, Karuna

L1CAM signaling through planar cell polarity generates SOX2 (+) metastatic progenitors in lung adenocarcinoma

L1CAM信号通过平面细胞极性在肺腺癌中产生SOX2(+)转移祖细胞

Park, Jin Suk; Kaygusuz, Yasemin; Kenum, Carson; He, Lan; Gatie, Mohamed I; Zhuang, Xueqian; Sharma, Roshan; Chaligné, Ronan; Bhanot, Umesh K; Koche, Richard P; Tammela, Tuomas; Hadjantonakis, Anna-Katerina; Rudin, Charles M; Massagué, Joan